Hutchmed Drc Stock Current Liabilities
| HCM Stock | USD 16.45 0.23 1.38% |
HUTCHMED DRC fundamentals help investors to digest information that contributes to HUTCHMED DRC's financial success or failures. It also enables traders to predict the movement of HUTCHMED Stock. The fundamental analysis module provides a way to measure HUTCHMED DRC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to HUTCHMED DRC stock.
At this time, HUTCHMED DRC's Total Current Liabilities is very stable compared to the past year. As of the 18th of April 2024, Non Current Liabilities Total is likely to grow to about 140 M, while Non Current Liabilities Other is likely to drop about 8.2 M. HUTCHMED | Current Liabilities |
HUTCHMED DRC Company Current Liabilities Analysis
HUTCHMED DRC's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current HUTCHMED DRC Current Liabilities | 96.7 M |
Most of HUTCHMED DRC's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, HUTCHMED DRC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
HUTCHMED Current Liabilities Driver Correlations
Understanding the fundamental principles of building solid financial models for HUTCHMED DRC is extremely important. It helps to project a fair market value of HUTCHMED Stock properly, considering its historical fundamentals such as Current Liabilities. Since HUTCHMED DRC's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of HUTCHMED DRC's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of HUTCHMED DRC's interrelated accounts and indicators.
Click cells to compare fundamentals
HUTCHMED Current Liabilities Historical Pattern
Today, most investors in HUTCHMED DRC Stock are looking for potential investment opportunities by analyzing not only static indicators but also various HUTCHMED DRC's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of HUTCHMED DRC current liabilities as a starting point in their analysis.
HUTCHMED DRC Current Liabilities |
| Timeline |
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
HUTCHMED Total Current Liabilities
Total Current Liabilities |
|
In accordance with the recently published financial statements, HUTCHMED DRC has a Current Liabilities of 96.7 M. This is 94.48% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current liabilities for all United States stocks is 98.78% higher than that of the company.
HUTCHMED Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses HUTCHMED DRC's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of HUTCHMED DRC could also be used in its relative valuation, which is a method of valuing HUTCHMED DRC by comparing valuation metrics of similar companies.HUTCHMED DRC is currently under evaluation in current liabilities category among related companies.
HUTCHMED DRC Current Valuation Drivers
We derive many important indicators used in calculating different scores of HUTCHMED DRC from analyzing HUTCHMED DRC's financial statements. These drivers represent accounts that assess HUTCHMED DRC's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of HUTCHMED DRC's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 3.3B | 4.5B | 5.6B | 2.5B | 3.1B | 2.9B | |
| Enterprise Value | 3.2B | 4.3B | 5.2B | 2.2B | 2.9B | 2.0B |
HUTCHMED Fundamentals
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.01 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | (0.31) % | ||||
| Current Valuation | 27.69 B | ||||
| Shares Outstanding | 170.73 M | ||||
| Shares Owned By Insiders | 0.12 % | ||||
| Shares Owned By Institutions | 9.43 % | ||||
| Number Of Shares Shorted | 501.45 K | ||||
| Price To Earning | 335.94 X | ||||
| Price To Book | 4.18 X | ||||
| Price To Sales | 3.74 X | ||||
| Revenue | 838 M | ||||
| Gross Profit | (271.59 M) | ||||
| EBITDA | 25.53 M | ||||
| Net Income | 100.78 M | ||||
| Cash And Equivalents | 829.71 M | ||||
| Cash Per Share | 4.91 X | ||||
| Total Debt | 86.13 M | ||||
| Current Ratio | 3.18 X | ||||
| Book Value Per Share | 0.86 X | ||||
| Cash Flow From Operations | 219.26 M | ||||
| Short Ratio | 3.90 X | ||||
| Earnings Per Share | 0.60 X | ||||
| Target Price | 28.47 | ||||
| Number Of Employees | 1.99 K | ||||
| Beta | 0.68 | ||||
| Market Capitalization | 3.06 B | ||||
| Total Asset | 1.28 B | ||||
| Retained Earnings | (870.87 M) | ||||
| Working Capital | 693.81 M | ||||
| Current Asset | 187.47 M | ||||
| Current Liabilities | 96.7 M | ||||
| Net Asset | 1.28 B |
About HUTCHMED DRC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze HUTCHMED DRC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HUTCHMED DRC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HUTCHMED DRC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out HUTCHMED DRC Piotroski F Score and HUTCHMED DRC Altman Z Score analysis. To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.Note that the HUTCHMED DRC information on this page should be used as a complementary analysis to other HUTCHMED DRC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for HUTCHMED Stock analysis
When running HUTCHMED DRC's price analysis, check to measure HUTCHMED DRC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HUTCHMED DRC is operating at the current time. Most of HUTCHMED DRC's value examination focuses on studying past and present price action to predict the probability of HUTCHMED DRC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HUTCHMED DRC's price. Additionally, you may evaluate how the addition of HUTCHMED DRC to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is HUTCHMED DRC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HUTCHMED DRC. If investors know HUTCHMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HUTCHMED DRC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.6 | Revenue Per Share 4.93 | Quarterly Revenue Growth 0.36 | Return On Assets 0.01 | Return On Equity 0.1465 |
The market value of HUTCHMED DRC is measured differently than its book value, which is the value of HUTCHMED that is recorded on the company's balance sheet. Investors also form their own opinion of HUTCHMED DRC's value that differs from its market value or its book value, called intrinsic value, which is HUTCHMED DRC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HUTCHMED DRC's market value can be influenced by many factors that don't directly affect HUTCHMED DRC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HUTCHMED DRC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.